14 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
%) (8 %) Change in valuation allowance, federal 24 % 23 % Change in valuation allowance, state 6 % 8 % Stock-based compensation 1 % — % R&D tax credits
8-K
EX-99.1
CRBU
Caribou Biosciences Inc
11 Mar 24
Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:22pm
revenue balance from AbbVie’s $30 million upfront payment in February 2021.
R&D expenses: Research and development expenses were $31.3 million
8-K
EX-99.1
CRBU
Caribou Biosciences Inc
7 Nov 23
Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
4:02pm
was the remaining deferred revenue balance from AbbVie’s $30 million upfront payment in February 2021.
R&D expenses: Research and development expenses were $28.6
8-K
EX-99.1
CRBU
Caribou Biosciences Inc
8 Aug 23
Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
4:03pm
by a revenue increase related to a veterinary therapeutics licensing agreement.
R&D expenses: Research and development expenses were $26.5 million
8-K
EX-99.2
u6y7d nv3h7sr
13 Jul 23
Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL
4:23pm
8-K
EX-99.1
fz7kw ecx
9 May 23
Caribou Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update
4:05pm
ARS
26xzp5xrn10
28 Apr 23
Annual report to shareholders
12:00am
8-K
EX-99.1
ealvzmx7 m8x5zz6k
8 Nov 22
Caribou Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
2vrkdfrqnac y3ymwx
9 Aug 22
Caribou Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-99.1
pjlcprdux6b
9 May 22
Caribou Biosciences Reports First Quarter 2022 Financial Results and Provides Business Updates
4:11pm
8-K
EX-99.1
n2x7hhmuz7i
21 Mar 22
Caribou Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:13pm
8-K
EX-99.1
hvybm34e8m47fl56jrbx
9 Nov 21
Caribou Biosciences Provides Business Update and Reports Third Quarter 2021 Financial Results
4:12pm
8-K
EX-99.1
1zupteth2tf e8bz4h
2 Sep 21
Caribou Biosciences Provides Business Update and Reports Second Quarter 2021 Financial Results
4:18pm
- Prev
- 1
- Next